My Story

Koen Kas is a healthcare futurist driven by the aim to make healthcare delightful, personalised, and ultimately preventive. He published his inspiring vision in 2 books. ‘Sick no more’ describes how we will transition from reactive sickcare to pro-active healthcare using digital health tools, datascience and omics insights, together with new design ideas. ‘Your guide to Delight’ is a roadmap towards creating health, dealing with change, introducing our personal Digital Twin as our permanent doctor keeping us healthy.

With Healthskouts, he inspires any healthcare stakeholder to Delight its customer – yes, also patients – using a newly developed Delight Thinking methodology. Healthskouts uncovers surprising insights and designs novel healthcare experiences. This way it helps its clients envision & validate unseen ways to compete in the scope of personalised, predictive and preventive health.

“Make healthcare delightful, personalised, and ultimately preventive”

Koen is guest professor Molecular Oncology & Didital health at the University of Ghent, Belgium. He chairs the scientific committee of the European Cancer Prevention Organisation. He is co-chair of the Healthcare & Life Sciences Working Group of the Digital Twin Consortium and advisor of the Digital Therapeutics Alliance (DTa). He is editor of the mHealth Journal & the European Journal of Cancer Prevention. He is an ambassador for health tech experience zone Health House and for VITO‘s citizen-centric data platform We Are (built on SOLID). He advises 5 pioneering healthcare companies, a startup incubator and an investor. He has over 300 international keynotes under his belt, including for many Fortune 500 companies.

Before, Koen spent 15 years in Executive positions at 4 leading biotech companies, combining that with academic cancer and omics research. As CSO Oncology of Thrombogenics he helped spin out Oncurious, developing a novel pediatric brain tumour drug into clinical trials. Koen was earlier founding CEO & CSO of Pronota, a protein biomarker company committed to better diagnosis and personalized medicine in the areas of ovarian cancer, preeclampsia, cardio-renal failure & sepsis. He was, prior to that Director drug discovery at Galapagos, one of the leading European life-sciences companies. Previously, he set up and directed the Cancer drug discovery program at Tibotec (now Johnson & Johnson).

“The future is no longer about being sick

He received his PhD degree in Biomedical Sciences from the University of Antwerp where he also obtained a degree in Business Administration. In 1999 he was appointed professor at the University of Leuven, Belgium and lecturer at Harvard University, Boston, USA. He is author of over 60 publications in international journals in the field of cancer, biomarkers, human genomics and proteomics. He authored over 20 patents and patent applications. He is a member of different scientific societies and received prestigious awards from NATO and the Collen Research Foundation and from the Royal Belgian Academy of Sciences and the Belgian Royal Academy of Medicine.
He started his career at the Center of Human Genetics in Leuven, elucidating the molecular basis of salivary gland tumors and the hereditary endocrine tumor syndrome MEN1.

Current Projects


Healthskouts inspires any healthcare stakeholder to Delight its customer.

By unlocking & connecting data silos, we uncover surprising insights and design novel experiences, as such helping our clients envision & validate unseen ways to compete in the scope of predictive and personalised health.

Read More


Fashiontech queen Jasna Rokegem and myself, announced more than just their partnership (“JRKK”) December 2017. They invited people to visit their first seminar at the And& Summit & Festival in Leuven, May 3, 2018. We are convinced that the marriage between FashTech and HealthTech allows us to create completely novel interfaces and solutions. Stay tuned to experience how connecting the dots between totally different worlds is the way to shape a future where sickcare turns healthcare !

Regulated Health Apps

We have created the global database of regulated health Apps that can be useful for patients, physicians and / or other key health players, along with useful information (iOS or Android, free or paying, which mark of approvals …). We hope that this will help physicians to make an informed decision about the use of mobile medical applications in their practice. We have developed also overveiews of any Digital Therapeutics (DTx) as well as all emerging Software-as-a-medical device applications.

We also invite you to improve these databases. Good or bad experiences can be useful for your colleagues. Obviously, any errata or updates may also always be reported via

Read More

Health House

I am an Ambassador to Health House.

Health House opens up new horizons in health technology by uniting health, high-tech and all the people around it. Providing hands-on interaction with cutting-edge technology and inspiration for research, business, and cooperations. Health House will turn every visit into a unique experience.

Here is a little movie.

If you have novel technology you would like to showcase, exposing you to policy makers, hospital and pharma directors, … please get in touch to discuss conditions and modalities (